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The niche that supports hematopoietic stem and progenitor cells (HSPC) in the 
bone marrow is a highly dynamic structure. It maintains core properties of HSPC 
in the steady state, and modulates their proliferation and differentiation in 
response to changing physiological demands or pathological insults.  The 
dynamic and environment-sensing properties of the niche are shared by the 
innate immune system. Thus, it is not surprising that innate immune cells, 
including macrophages and neutrophils, are now recognized as important 
regulators of the hematopoietic niche, and ultimately of the stem cells from 
which they derive. This review synthesizes emerging concepts on niche 
regulation by immune cells, with a particular emphasis on neutrophils. We argue 
that the unique developmental, circadian and migratory properties of neutrophils 
underlie their critical contributions as regulators of the hematopoietic niche. 
 
Introduction 
Neutrophils are innate, polymorphonuclear leukocytes that act as the first line of host 
defense against invading pathogens. Central to their function is their ability to be 
recruited to sites of infection, to recognize and phagocytose microbes, and to kill 
pathogens through a combination of cytotoxic mechanisms (reviewed in 1). These 
include the production of reactive oxygen species (ROS), the release of antimicrobial 
peptides, and the extrusion of their nuclear contents to form extracellular traps (NETs). 
Beyond their prominent immune roles, recent years have seen a remarkable 
emergence of unexpected non-immune functions of neutrophils in homeostasis as well 
as in diseases with an important inflammatory component, including systemic lupus 
and cancer 2.  
A wealth of recent studies have begun to dissect the function of immune cells, 
including neutrophils, in the bone marrow. These studies most prominently highlight the 
diversity of properties of a cell type that not long ago was regarded as purely cytotoxic 
and pro-inflammatory. Here, we review fundamental aspects of neutrophil and bone 
marrow niche biology, and discuss the functional interplay between neutrophils and 
other immune cells within these niches that help to preserve HSPC. We finally consider 
temporal regulation of the hematopoietic niche driven in part by the unique circadian 
properties of neutrophils, as this highlights novel layers of interaction between 




Developing neutrophils and neutrophils in development 
Neutrophils are short-lived cells, as they are generally believed to circulate for only 6-
12 h in mice and humans 3 4. Their short lifespan in circulation demands constant 
production and release from the bone marrow, with an estimated production rate in 
humans of around 1010 cells per day 5. Given their indispensable anti-microbial roles 
but potential toxic activity in tissues, both excessive and deficient production of 
neutrophils can have major detrimental consequences for the organism. Indeed, 
neutrophil homeostasis is tightly regulated through a balance between granulopoiesis, 
storage and egress from the bone marrow, intravascular margination, clearance, 
constitutive death by apoptosis 6, and elimination through phagocytosis in specific 
organs 5,7. 
 
Neutrophils are formed within the bone marrow through a series of progressively 
differentiated precursors in a process termed granulopoiesis. The most immature long-
term or short-term stem cells give rise to multipotent progenitors, common myeloid 
progenitors and granulocyte-macrophage progenitors (GMPs). Only recently, GMPs 
have been shown to produce neutrophil-committed proliferative precursors (NeP and 
pre-Neu) that differentiate into non-proliferative immature neutrophils, and give rise to 
the mature neutrophils which are released into the bloodstream 8,9 (Figure 1).  
 
The ultimate elimination of neutrophils is as important as their production, and these 
two processes must be tightly coordinated to maintain a constant supply and steady 
number of neutrophils in blood 10. This is important because overproduction of 
neutrophils can aggravate cytotoxic damage in healthy tissues as seen in many 
inflammatory diseases, whereas neutropenia inevitably results in recurrent infections 
and, paradoxically, chronic inflammatory states 11. A key mechanism regulating 
neutrophil homeostasis was reported in a seminal study by Ley and colleagues, and 
involves the IL-23/IL-17/G-CSF feedback circuit 12. Senescent neutrophils that migrate 
to peripheral tissues are phagocytosed by tissue-resident phagocytes, including 
macrophages and dendritic cells 12 in a process that relies, at least partially, on the 
Liver X receptors (LXR) 13. Activation of LXR in engulfing phagocytes inhibits 
transcription of Il23, a cytokine that boosts granulopoiesis by promoting the production 
of IL-17, which in turn induces the production by stromal cells of G-CSF, the main 
granulopoietic factor 13. This homeostatic loop becomes evident in mice deficient in 
adhesion molecules, in which neutrophils have impeded egress from blood into tissues 
and consequent reduced uptake by tissue phagocytes, leading to unleashed 
production of IL-23 and IL-17, and therefore supra-physiological levels of G-CSF that 
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drive the overproduction and release of neutrophils into blood 12. The importance of this 
study was not only the identification of a mechanism for homeostatic regulation of 
neutrophil numbers, it also provided the first link between neutrophils and functional 
regulation of hematopoiesis. The receptor CXCR2 is not only needed for the normal 
release of neutrophils from the bone marrow into blood, but also for their migration into 
tissues. Deficiency in Cxcr2 or its ligand CXCL5 produced by intestinal cells also 
results in dysregulation of the IL-17/G-CSF axis and microbiota composition, resulting 
in elevated medullary granulopoiesis and neutrophilia 12,14. Interestingly, studies in 
antibiotic-treated mice demonstrated a reciprocal regulation, whereby the microbiota is 
an important innate stimulus for IL-17-producing cells in the intestine and G-CSF 
production, thereby participating in neutrophil production and immune competence of 
the organism 15. 
 
The crosstalk between mature immune cells and HSCs is already evident from 
embryonic life, a stage at which specific populations of primitive immune cells have an 
essential role in determining HSC fate. For instance, yolk-sac derived macrophages 
that migrate to the fetal liver around embryonic day 10.5 contribute substantially to the 
first wave of hematopoiesis 16. The fetal liver serves as the main hematopoietic organ 
during embryonic development until HSCs move to the bone marrow, which becomes 
the primary site of hematopoiesis from the perinatal period onwards. It is striking that 
yolk-sac-derived macrophages persist in functionally distinct tissues in the adulthood 
such as in brain (microglia), epidermis (Langerhans cells) and lung (alveolar 
macrophages) 16, among many other tissues, implying that early dissemination of 
immune cells is important for prenatal and adult life in hematopoietic and non-
hematopoietic organs. Also during embryonic life, a subset of primitive neutrophils that 
lie in the dorsal aorta of the zebrafish embryo was shown to play an important role in 
determining HSC fate 17. These cells were shown to be the main source of TNFα, a 
cytokine needed for the emergence and specification of HSC in the embryo, thereby 
providing an example of early immune-driven determination of HSC fate in 
development 17. 
 
The hematopoietic bone marrow niche  
HSPC proliferate and differentiate in a highly-regulated manner, thus giving rise to all 
immune subsets in the bone marrow, or after migrating into extramedullary 
hematopoietic or lymphoid organs. Regulation of hematopoiesis requires a highly 
dynamic and tightly regulated orchestration of stem cell-intrinsic programs 18. Notably, 
the realization that HSPC lost repopulating ability when placed outside the marrow led 
5 
 
to the formulation of the “niche” concept, which proposed a specific stem cell-
supportive environment inside the medullary space 19,20. This supportive niche is 
comprised by a plethora of cellular components, which regulate HSPC activity by 
supplying growth regulators and retention factors. The specific location of HSC in the 
vast medullary space has been controversial (reviewed in 21); many studies pointed to 
localization close to the endosteal region 22-25, whereas others studies suggested that 
HSC localized randomly in the bone marrow or were perisinusoidal 26. It has become 
increasingly clear that the vast majority of HSC in the marrow localize adjacent to blood 
vessels, therefore proximal to perivascular cells. Endothelial cells are key sources of 
CXCL12 and the cytokine stem cell factor (SCF) that maintain HSPC 27-30. In addition to 
the endothelium, rare populations of perivascular cells are also key sources of CXCL12 
and SCF. Aided by the use of multiparametric imaging with different markers and 
lineage-specific reporter genes, the complex heterogeneity that exists among stromal 
cells is now being clarified. Based on the brightness and morphology of Nestin-GFP+ 
cells, two subsets of mesenchymal progenitor cells were identified 24. Nes-GFP-bright 
cells are scarce and associate with arterioles, while the GFP-dim cells are more 
abundant, reticular shaped, and associate with sinusoids. Interestingly, quiescent HSC 
preferentially localize near arteriolar cells. Nes-GFP bright cells express the pericyte 
markers NG2+ and α-smooth muscle actin and produce abundant CXCL12 needed for 
HSC localization and quiescence 31. In contrast, Nes-GFP dim cells, which can be also 
identified by expression of the leptin receptor (LepR+), are an important source of SCF 
that help maintain constant numbers of HSC in the bone marrow 31.  
 
Besides cells of mesenchymal origin, early findings provided strong evidence that the 
nervous system also regulates the hematopoietic niche and HSPC properties 32-34. 
Sympathetic nerves that align with the medullary vasculature regulate the expression 
of stromal CXCL12 and thereby the traffic of HSPC in and out of the bone marrow 
under homeostasis or stress conditions 34-36. Specifically, release of the 
neurotransmitter noradrenaline by sympathetic nerves signals stromal cells through the 
β3-adrenergic receptor, leading to rapid downregulation of Cxcl12 expression. 
Interestingly, studies showed that noradrenaline secretion follows a circadian pattern 
controlled by the core genes of the molecular clock, which elegantly explained the 
diurnal release of HSPC into blood 34. GFAP+ non-myelinating Schwann cells that 
ensheath sympathetic nerves are also functional regulators of HSC proliferation by 





Niche regulation by hematopoietic descendants 
In addition to stromal niche components and sympathetic nerves, a growing list of 
hematopoietic cells that descend from HSPC have been shown to influence HSC 
homeostasis and fate, including macrophages, megakaryocytes (MK), regulatory T 
cells (Tregs) and neutrophils. Bone marrow-resident macrophages were the first 
among this progeny shown to favor retention of HSPC by reinforcing the function of 
Nestin+ cells and osteoblasts 38-40, an effect that opposes the niche-inhibiting and 
mobilizing effects of the sympathetic nervous system. Experiments in which CD169+ 
macrophages were acutely depleted demonstrated that their elimination was sufficient 
to induce HSPC egress into the bloodstream 38. Interestingly, macrophages regulate 
HSPC also under stress; in a transplantation setting, radiation eliminates the majority 
of leukocytes but spares a population of resident macrophages that repopulate the 
spleen and marrow via autonomous cell division 41. These CD169+ radiation-resistant 
macrophages are needed for optimal donor-derived HSC reconstitution 41.  
 
MK, the precursors of platelets, are in close contact with sinusoidal vessels in the 
marrow, where they extend cytoplasmic protrusions into the vessel lumen to release 
newly produced platelets. A subset of HSC localizes near MK in the sinusoids, and this 
spatial relationship was shown by several studies to correlate with regulation of the 
HSC pool size 42,43. Specifically, HSPC expanded dramatically after depletion of MK in 
Cxcl4-Cre; iDTR mice. These effects could be pinned down to the production of key 
regulators of HSPC proliferation by MK, including CXCL4 and TGFβ1, both of which 
promote HSC quiescence. Consequently, deletion of these factors from MKs resulted 
in increased HSC numbers in the steady state. In contrast to these results, a separate 
study showed that depletion of MK resulted in reduction of HSC numbers despite a 
similar loss of quiescence, an effect that was accounted for by the production of 
thrombopoietin 44. Besides homeostasis, MK can promote HSPC recovery after 
ablation with irradiation by secretion of FGF1 43, or indirectly through osteoblast 
expansion 45. 
 
The bone marrow is a major reservoir of a population of CD4+CD25+ T lymphocytes 
with immune-modulatory functions, or Tregs 46. A subset of Tregs that expresses high 
levels of the stem marker CD150 was found in the endosteal region of the bone 
marrow, proximal to HSPC 47,48. CD150high Tregs control HSPC quiescence and 
engraftment through the production of adenosine generated via the CD39 ectoenzyme 
48, and it has been proposed that Tregs confer immune-privilege to the HSPC niche 47.  
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In summary, ample evidence now shows that the hematopoietic niche is regulated, 
secured and nurtured by the very descendants of HSPC residing therein, perhaps 
providing a regulatory loop that feeds on output cells and benefits from the exquisite 
sensing properties of mature immune cells. Given the precedents described above, it is 
not surprising that other hematopoietic cell lineages can actively regulate the bone 
marrow niche. Below, we focus our discussion on neutrophils, the most abundant 
among HSPC descendants, whose extreme sensitivity to stress, tissue damage and 
even temporal cues may provide additional layers of regulation of the bone marrow 
niche.   
 
Regulation of HSPC quiescence and proliferation by neutrophils 
Besides perivascular cells and MK, myeloid cells have been shown to maintain HSPC 
quiescence through a negative feedback histaminergic circuit. Indeed, a myeloid 
population expressing the histidine decarboxylase (Hdc) produces histamine (Figure 
1). This biogenic amine inhibits active cycling of a myeloid-biased Hdchigh HSC 
population (MB-HSC) through the histamine receptor 2 (H2R), and promotes its self-
renewal 49. This pathway elicited by granulocytes and possibly other myeloid subsets 
was important for HSPC maintenance, because ablation of histamine producing cells 
caused MB-HSC and progenitors to exit dormancy and induced loss of serial 
transplantation capacity 49.  
Along the same line, neutrophils stimulate emergency myelopoiesis via production of 
ROS, which oxidizes the PTEN phosphatase to directly activate HSPC proliferation 
upon acute infection or inflammation 50. We expect that, as we continue to extend our 
knowledge on neutrophil biology in the bone marrow, new mechanisms by which these 
cells directly regulate HSPC fate will emerge. At present, however, the most prominent 
known roles of neutrophils on HSPC are mediated through regulation of their niche, as 
discussed below. 
 
Role of neutrophils in regeneration of the bone marrow niche 
Hematopoietic stem cell transplantation (HSCT) remains the only curative treatment for 
most malignant and non-malignant hematopoietic diseases. In this procedure, the 
diseased host hematopoietic cells are wiped out by high dose chemotherapy or 
radiotherapy. Healthy HSPC and more mature hematopoietic cells are then transferred 
into the recipient’s circulation where they home to the bone marrow to engraft and 
regenerate a new hematopoietic system. Unfortunately, the treatments used to 
eliminate the host hematopoietic cells invariably cause an almost complete destruction 
of the vascular HSPC niche in the bone marrow. Specifically, they ablate the sinusoidal 
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vasculature and associated perivascular cells, while leaving arteries and arterioles 
mostly intact 51-53. Although the transplanted HSPC can engraft for short periods near 
endosteal arterioles and MK 43,45, long-term restoration of normal hematopoiesis 
demands reestablishment of a healthy sinusoidal network 51-53, as initially demonstrated 
by Rafii and colleagues. Indeed, deletion of vascular-borne VEGFR2 does not affect 
baseline hematopoiesis, but strongly impairs regeneration of the vasculature and the 
hematopoietic compartment after injury 52. In addition to the aforementioned functions 
of nutrient support and providing a niche for HSPC, the sinusoidal network also 
produces many molecules like Notch ligands and pleiotrophin that promote HSPC 
engraftment specifically after injury 51,54-57. Thus, regeneration of the sinusoidal network 
is the rate-limiting step in restoring healthy hematopoiesis after HSCT, and a long-
standing question has been which environmental cues instruct vascular regeneration of 
the damaged niche. 
 
We recently discovered that bone marrow Gr1+ CD115NEG neutrophils drive sinusoidal 
regeneration after transplantation 58. We noticed that, in mice transplanted with total 
bone marrow mononuclear cells, regeneration of the host vascular niche correlated 
directly with the number of donor hematopoietic cells transplanted, and adoptive 
transfer experiments demonstrated that only bone marrow neutrophils were capable of 
driving sinusoidal regeneration. In agreement, depletion of mature neutrophils from the 
initial graft or genetic ablation of donor-derived neutrophils delayed regeneration of the 
vasculature. These experiments indicated that neutrophils are both necessary and 
sufficient to drive vascular regeneration after HSCT. Imaging experiments showed that 
bone marrow neutrophils are selectively recruited to the injured sinusoids, where they 
secrete TNFα, a cytokine that promoted endothelial cell survival and regeneration of 
the sinusoids58 (Figure 2). After transplantation, donor HSPC initiate a pro-regenerative 
program that greatly increases their proliferation and their capacity to generate 
neutrophils and other myeloid cells 59. These findings suggested that newly generated 
neutrophils can promote regeneration of the sinusoidal network, which in turn facilitates 
hematopoietic progenitor engraftment 58. This positive feedback loop continues until the 
sinusoidal network is restored and the bone marrow returns to homeostasis. 
Surprisingly, the signals and mechanisms that sense regeneration of the sinusoidal 
niche, halt further vessel growth, and induce HSPC return to quiescence are almost 
completely unknown, although it is likely that TGFβ signaling plays a major role in this 
process 53,60. Identification of these mechanisms may lead to the development of better 
therapies to promote faster myeloid cell recovery, with restoration of innate immunity 
and reduced infections after HSCT.  
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Although the role of neutrophils in bone marrow regeneration was previously unclear, it 
was well established that they contributed to tissue regeneration (reviewed in 61). 
Neutrophils are recruited to injured tissues via DAMPs (damage-associated molecular 
patterns) 62, where they can exert both positive and negative effects in the regeneration 
program. This is dependent on cellular context and in the amount and type of 
neutrophils recruited to each tissue 61,63. In the context of vascular development and 
repair, it is now clear that different neutrophils subsets crosstalk with endothelial cells 
to regulate their function.  
As described above, embryonic neutrophils induce generation of definitive HSC by 
signaling via TNFα to the hemogenic endothelium 17. The Phillipson group identified a 
VEGFR1+ neutrophil subset in the circulation (representing ~5% of blood neutrophils) 
that is selectively recruited to hypoxic tissues, where they induce vessel growth via 
MMP9 release 64-66. Intriguingly, however, blood-borne neutrophils are unable to induce 
vascular regeneration in the marrow despite expressing high amounts of TNFα, a 
limitation that may reflect their inability to home to injured sinusoids after adoptive 
transfer 58. An emerging concept is that neutrophils are a heterogeneous population 
both in tissues and in peripheral blood, and that they can adopt unique physiological 
functions 67,68. In the particular case of medullary regeneration, we highlight that there 
are at least two subsets of angiogenic neutrophils, one in the bone marrow that acts on 
niche-associated sinusoids, and one in the periphery that acts on peripheral vessels. A 
recent study by the Ng group also showed that classically-defined bone marrow 
Gr1+CD115NEG neutrophils are in fact a heterogeneous population that comprises a 
proliferating neutrophil progenitor as well as immature and mature neutrophils with 
transcriptional signatures distinct from those of circulating neutrophils 8. It will be 
interesting to dissect the behavior of each of these medullary neutrophil subsets after 
HSCT and their contribution to vascular niche regeneration.  
Bone marrow neutrophils are recruited specifically to injured sinusoids. This direct 
interaction is clearly important for the sinusoids as areas of the bone marrow that have 
no neutrophils showed no sinusoidal regeneration 58. In the steady state, neutrophil 
trafficking is regulated, almost exclusively, via CXCR2 and CXCR4 69. However, 
pharmacological blockade of both pathways does not affect neutrophil recruitment to 
injured vessels 58, thereby indicating the existence of an unidentified mechanism in the 
sinusoids, induced by damage to the vasculature that specifically recruits neutrophils to 
injured bone marrow vessels. 
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In addition to aiding regeneration of the vascular niche, neutrophils have been reported 
to support niche activity by enhancing the capacity of pre-osteoblastic cells to produce 
osteopontin, an important retention factor for HSPC in the marrow 70. Interestingly, 
adrenergic stimulation of neutrophils through the β3 receptor induced production of 
prostaglandin E2, a well-known support factor for hematopoiesis 71, which in turn 
induced osteoblastic activity through the EP4 receptor 70. Thus, neutrophils appear to 
counteract to some extent the inhibitory effects that catecholamines exert on the niche, 
thereby preventing excessive HSPC mobilization (Figure 2). The identification of 
neutrophils as intermediary and regulators of the mobilization process provide 
important mechanistic links between the various pathways that regulate hematopoietic 
niches.  
Circadian regulation of the hematopoietic niche 
In almost all life forms on Earth, the planet’s rotation have led to the evolution of daily 
circadian cycles of 24h. In mammals, peripheral clocks are normally synchronized with 
the environment by entrainment from daily exposure to light-dark cycles. The central 
circadian pacemaker located in the suprachiasmatic nuclei receives photic information 
conducted from the retina. The synchrony between autonomous circadian clocks found 
in all major organs and tissues is maintained by a complex network, involving neuronal 
signaling, secretion of hormones, and metabolic cues (reviewed in 72). As discussed 
above, the bone marrow is extensively innervated by autonomic nerve fibers, including 
sympathetic nerves, which play important physiological roles in the bone marrow. 
Sympathetic nerves have been shown to be responsible for cytokine-elicited 
mobilization of HSPC outside of the bone marrow into blood 32, although active 
signaling in monocytic cells has also been demonstrated 39. G-CSF, a cytokine broadly 
used in the clinic to mobilize HSPC into circulation for transplantation therapies, 
promotes the release of noradrenaline by autonomic neurons located in the periphery. 
Released adrenaline mediates the suppression of osteoblasts located in the endosteal 
marrow, thereby reducing the synthesis of CXCL12 and causing HSPC mobilization 32. 
Additionally, sympathetic nerves regulate perivascular Nestin-GFP+ stem cells by 
acting on β3 adrenergic receptors 35. This neural-mesenchymal axis is responsible for 
the circadian expression of CXCL12 by bone marrow stromal cells, which causes the 
homeostatic release of HSPC into circulation 34. In mice, the lowest levels of CXCL12 
protein in the medullary space coincide with HSPC egress around zeitgeber time 5 
(ZT5, or 5 hr after the onset of the light), and the highest CXCL12 levels occur at ZT13 
and correlate with the lowest numbers of circulating HSPC 34. In contrast to mice, 
11 
 
humans display inverted circadian oscillations with maximum levels of progenitors in 
blood in the evening 73.  
Given the bidirectional flux between blood and marrow, it is not surprising that 
adrenergic nerves also control the expression of endothelial-adhesion molecules in the 
medullary vasculature, as these adhesion molecules are necessary for HSPC homing 
back to the marrow 74. It is also likely that a cross talk exists between the levels of the 
chemokine CXCL12 and those of endothelial-adhesion molecules; for instance, in mice 
higher levels of CXCL12 at night correlate with a higher retention of hematopoietic 
stem cells in the bone marrow. The genuine circadian nature of this process was 
illustrated by jet-lag experiments showing that repeated shifts in light cycle was 
sufficient to ablate circadian HSPC recruitment into tissues 74.  
Interestingly, much like HSPC, mature leukocytes infiltrate the bone marrow in a 
circadian manner 74, with peak homing to the marrow and other organs at ZT13 in 
mice. The circadian migration of mature leukocytes (and HSPC) may be beneficial to 
provide a readily available set of tissue-resident leukocytes that mediate immune 
defense during the animal’s active phase, when the individual’s probability of injury or 
encountering pathogens is highest. The circadian fluxes of mature leukocytes that 
return to the marrow also suggest potential regulation of bone marrow niches by cells 
that have “sampled” the extramedullary environment. For example, it is likely that 
various myeloid cell subsets regulate circadian oscillations in HSPC activity through 
TNFα. Indeed, this cytokine has been shown to regulate circadian migration, 
proliferation and differentiation through modulation of ROS and melatonin signaling in 
HSPC, and its medullary levels are controlled in part by neutrophils and monocytes 
58,75. 
Neutrophil aging and temporal control of the hematopoietic niche 
Neutrophils are the most abundant myeloid population in the bone marrow. Because of 
the short lifespan, vast amounts of neutrophils must be released into the blood every 
day to maintain homeostatic numbers 10. This implies that, even under homeostatic 
conditions, large numbers must also be eliminated every day, yet possible functions for 
these naturally-cleared neutrophils were enigmatic 76,77. 
Only recently, we and others discovered that circulating neutrophils undergo circadian 
fluctuations that affect not only neutrophil numbers, but also their phenotype. This 
spontaneous change over time is referred to as neutrophil aging 78. As neutrophils age 
in the circulation their repertoire of surface receptors change: they up-regulate markers 
like CXCR4 and VLA-4, both of which are important for the retention in and homing to 
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the marrow 76,77,79, and downregulate others including CD62L (L-selectin) and CXCR2 
(77 and Adrover, unpublished data October 2018) (Figure 1). This CXCR4hi CD62Llo 
population of aged neutrophils follows marked circadian oscillations throughout the day 
and are completely cleared out from circulation by night (ZT13), when the active 
behavioral phase of the mice begins 77. Interestingly, recent studies in mice have 
proposed that aged neutrophils gain immune-competence by enhancing β2 integrin-
dependent adhesion, as well as their capacity to phagocytose and to form DNA-based 
extracellular traps (NETs;80,81). In addition, microbiota-derived metabolites have been 
proposed to drive neutrophil aging through Toll-like receptor signaling 81, although our 
own data suggest that cell-intrinsic circadian programs can also drive aging (Adrover, 
unpublished data October 2018). Thus, while the evolutionary drive and physiological 
role of this diurnal aging process of neutrophils remains to be fully elucidated, it is 
tempting to speculate that diurnal “priming” of neutrophils is needed for these cells to 
fully mature and to fulfil additional functions after their lifetime in blood, once they have 
cleared into tissues.  
Aged neutrophils that clear from the circulation into tissues are believed to be 
ultimately engulfed and eliminated by tissues macrophages 78,82. The bone marrow is 
one of the tissues in which aged neutrophils are cleared in larger numbers.  Clearance 
in this organ not only serves to control neutrophil numbers but, importantly, generates 
homeostatic signals that modulate the bone marrow niche 77.  When aged neutrophils 
infiltrate the mouse bone marrow between ZT5 and ZT13, they are engulfed by tissue-
resident macrophages. This efferocytic process generates LXR-dependent, but 
otherwise undefined signals that down-regulate the number of niche cells and, 
consequently, the amount of CXCL12 in the marrow, thereby promoting HSPC egress 
into blood (Figure 2). Consistently, the number of CXCL12-producing reticular cells and 
osteoblasts in the bone marrow increase when neutrophils are experimentally 
depleted, indicating that neutrophils modulate the size of the niche stroma. More 
importantly, interruption of this natural niche-inhibitory pathway by depletion of 
circulating neutrophils or macrophages completely blunted the diurnal oscillations of 
HSPC in blood, indicating that circadian clearance of aged neutrophils drives rhythms 
in the hematopoietic niche 77. These findings in mice reveal a coalescence of 
hematopoietic, neural and immune inputs in the bone marrow to provide multi-layered 
regulation of hematopoiesis. Importantly, alterations of this axis appear to powerfully 




Contrary to common belief, homeostatic clearance of aged neutrophils is not unique to 
the bone marrow, spleen or liver; it also takes place in many extramedullary tissues 
such as the lung, skin or muscle in which they can perform tissue-specific roles 2,78,86. 
Surprisingly, infiltration of neutrophils in the intestinal mucosa enhances bone marrow 
niche activity remotely, by preventing Il23 transcription in intestinal macrophages. 
Similar to the aforementioned “neutrostat” model 12, inhibition of this cytokine results in 
reduced systemic levels of G-CSF and preserved niche function, thereby preventing 
excessive mobilization of HSPC into blood. However, unlike the rhythmic inhibitory 
roles of marrow-infiltrating neutrophils 77, infiltration in the intestine does not follow 
circadian patterns, and consequently niche regulation from the intestine does not 
influence the diurnal oscillations of circulating HSPC 86 (Figure 2). These recent 
findings expand the regulatory mechanisms of hematopoietic niches to include distant 
anatomical sites, and are consistent with the reported effects of microbiota-derived 
signals emanating from the gut in regulating stem cell and niche activity 87-89.  
Concluding remarks 
It is becoming increasingly clear that dysregulation of hematopoiesis is an important 
underlying driver of disease. Therefore understanding the multiple regulatory 
mechanisms of this highly dynamic process becomes a question of major biomedical 
relevance. Disturbance of neural regulation of the niche occurs during organismal 
aging 90 and is also prominent in the context of ischemic disease 91,92, whereas 
dysregulated cytokine pathways appear to be more common in cancer 83. We have 
discussed here emerging evidence that neutrophils provide additional layers of 
regulation in hematopoiesis. The realization that neutrophils influence multiple aspects 
of niche physiology, from maintenance of the mesenchymal niche to HSPC 
quiescence, demands for urgent evaluation of their contribution to inflammatory 
disease and hematological malignancies. Neutrophils are also instrumental in 
regenerating the injured vascular niche and may provide strategies to accelerate 
regeneration of patients undergoing HSCT. More generally, we propose that the unique 
temporal properties of neutrophils, their basal presence in multiple tissues, and 
exquisite capacity to sense danger make these cells ideal intermediaries for niche 
regulation and repair not only in the bone marrow, but also other in tissues that 
demand rapid responses to environmental challenges.   
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Figure 1. Functional and phenotypic diversity of neutrophils in the bone marrow. 
Neutrophils are produced inside the bone marrow through progressive maturation of 
hematopoietic progenitors (LT-HSC to GMPs).  Proliferative precursors (NeP and 
preNeu) differentiate into immature neutrophils and finally into mature neutrophils that 
are released into blood. A fraction of aged neutrophils return into the marrow after 
several hours in the circulation. Top and bottom panels indicate specific phenotypes 
and functions, respectively, of neutrophils at each stage of their life cycle.  
 
Figure 2. Regulation of the hematopoietic bone marrow niche. The sympathetic 
nervous system (SNS) exerts control on the HSC niche by the circadian release of 
catecholamine, which targets β3-adrenergic receptors on stroma cells. The same 
signals can act through neutrophils to produce prostaglandin E2 (PGE2) and stimulate 
the osteoblastic niche. The stromal niche is also circadianally regulated by aged 
neutrophils that return to the bone marrow after only several hours in the circulation. 
Aged neutrophils that infiltrate the bone marrow are engulfed by macrophages and 
activation of the LXR receptors lead to inhibition of the hematopoietic niche. Excessive 
G-CSF production associated with several inflammatory processes or impaired 
neutrophil clearance in extramedullary tissues is also a potent inhibitor of the HSPC 
niche. All these regulatory mechanisms ultimately inhibit production of CXCL12, 
thereby promoting HSPC egress into blood. This has been shown in the intestine, 
where neutrophil infiltration in the mucosa and engulfment of neutrophils by tissue-
resident macrophages inhibits the IL-23/IL-17/G-CSF axis and remotely supports niche 
activity in a circadian-independent manner. Boxes indicate the presence or absence of 
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